Common Stock, $0.001 par value

Cyclacel Pharmaceuticals, Inc.

200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ, 07922

Item 5(a) is hereby amended and restated as follows: The aggregate percentage of Shares owned by the Reporting Person is based upon 1,583,965 shares of Common Stock outstanding as of July 10, 2025, as reported in the Issuer's Registration Statement on Form S-1, which was filed with the Securities and Exchange Commission on July 30, 2025. As of the close of business on August 5, 2025, the Reporting Person did not beneficially own any Shares. Percentage: 0%

Item 5(b) is hereby amended and restated as follows: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 0

Item 5(c) is hereby amended and restated as follows: The transactions in the Shares by the Reporting Persons during the past sixty days are set forth in more detail in Exhibit 1 and are incorporated herein by reference.